Marie Tré-Hardy to Humans
This is a "connection" page, showing publications Marie Tré-Hardy has written about Humans.
Connection Strength
0.088
-
Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary. J Infect. 2021 11; 83(5):559-564.
Score: 0.008
-
The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another. J Virol Methods. 2021 11; 297:114248.
Score: 0.008
-
Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers. J Infect. 2021 09; 83(3):381-412.
Score: 0.008
-
Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance. J Med Virol. 2021 Oct; 93(10):5783-5788.
Score: 0.008
-
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers. J Infect. 2021 08; 83(2):237-279.
Score: 0.008
-
Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time. J Med Virol. 2021 04; 93(4):2538-2542.
Score: 0.007
-
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak. J Infect. 2021 01; 82(1):159-198.
Score: 0.007
-
Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020 Jul 28; 58(8):1357-1364.
Score: 0.007
-
Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021 02; 93(2):803-811.
Score: 0.007
-
The role of serology for COVID-19 control: Population, kinetics and test performance do matter. J Infect. 2020 08; 81(2):e91-e92.
Score: 0.007
-
MALDI-TOF MS identification and antimicrobial susceptibility testing directly from positive enrichment broth. J Microbiol Methods. 2017 10; 141:32-34.
Score: 0.006
-
Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients. J Med Virol. 2021 May; 93(5):3277-3281.
Score: 0.002
-
High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Clin Biochem. 2020 Dec; 86:23-27.
Score: 0.002
-
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies. Clin Chem. 2020 08 01; 66(8):1104-1106.
Score: 0.002
-
The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium. BMC Public Health. 2019 May 17; 19(1):597.
Score: 0.002
-
Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms. Appl Microbiol Biotechnol. 2010 Sep; 88(1):251-63.
Score: 0.001